$9.58
-0.26-2.64%
Pre-Market: Sep 20, 9:25 AM EDT
15 minutes delayed
Addex Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Addex Therapeutics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2021 | 2021-11-04 | $-14.40 | $-14.40 | 0.00 % |
Jun 2021 | 2021-08-05 | $-18.00 | $-13.00 | -38.5 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Sep 2023 | 2023-11-29 | $370.87K | $700.00K | -47.0 % |
Sep 2021 | 2021-11-04 | $825.37K | $420.00K | 96.5 % |
Jun 2021 | 2021-08-05 | $1.18M | $260.00K | 452307600.0 % |
Addex Therapeutics (ADXN) is scheduled to report earnings on November 27, 2024. The last reported earnings were for reported on June 6, 2024 for Q1.
The Actual EPS was $-1.37, which missed the estimate of $0.00.
The Actual Revenue was $268.8K, which beat the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.